As of 2026-01-09, the EV/EBITDA ratio of Pliant Therapeutics Inc (PLRX) is -0.09. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PLRX's latest enterprise value is 19.66 mil USD. PLRX's TTM EBITDA according to its financial statements is -219.95 mil USD. Dividing these 2 quantities gives us the above PLRX EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |
| 2025-12-31 | -0.05 |
| 2025-12-30 | -0.05 |
| 2025-12-29 | -0.06 |
| 2025-12-26 | -0.05 |
| 2025-12-24 | -0.06 |
| 2025-12-23 | -0.05 |
| 2025-12-22 | -0.06 |
| 2025-12-19 | -0.06 |
| 2025-12-18 | -0.05 |
| 2025-12-17 | -0.05 |
| 2025-12-16 | -0.06 |
| 2025-12-15 | -0.06 |
| 2025-12-12 | -0.06 |
| 2025-12-11 | -0.08 |
| 2025-12-10 | -0.07 |
| 2025-12-09 | -0.06 |
| 2025-12-08 | -0.07 |
| 2025-12-05 | -0.05 |
| 2025-12-04 | -0.08 |
| 2025-12-03 | -0.14 |
| 2025-12-02 | -0.13 |
| 2025-12-01 | -0.14 |
| 2025-11-28 | -0.16 |
| 2025-11-26 | -0.15 |
| 2025-11-25 | -0.15 |
| 2025-11-24 | -0.15 |
| 2025-11-21 | -0.15 |
| 2025-11-20 | -0.15 |
| 2025-11-19 | -0.13 |
| 2025-11-18 | -0.15 |
| 2025-11-17 | -0.17 |
| 2025-11-14 | -0.18 |
| 2025-11-13 | -0.19 |
| 2025-11-12 | -0.22 |
| 2025-11-11 | -0.18 |
| 2025-11-10 | -0.16 |
| 2025-11-07 | -0.16 |
| 2025-11-06 | -0.14 |
| 2025-11-05 | -0.17 |
| 2025-11-04 | -0.16 |
| 2025-11-03 | -0.18 |
| 2025-10-31 | -0.18 |
| 2025-10-30 | -0.17 |
| 2025-10-29 | -0.20 |
| 2025-10-28 | -0.21 |
| 2025-10-27 | -0.22 |
| 2025-10-24 | -0.22 |
| 2025-10-23 | -0.20 |
| 2025-10-22 | -0.22 |
| 2025-10-21 | -0.23 |